Canada markets closed

Jeil Pharmaceutical Co.,Ltd (271980.KS)

KSE - KSE Delayed Price. Currency in KRW
Add to watchlist
15,190.000.00 (0.00%)
At close: 03:30PM KST
Currency in KRW

Valuation Measures4

Market Cap (intraday) 221.34B
Enterprise Value 257.54B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.31
Price/Book (mrq)1.43
Enterprise Value/Revenue 0.36
Enterprise Value/EBITDA 339.17

Trading Information

Stock Price History

Beta (5Y Monthly) 1.12
52-Week Change 3-18.86%
S&P500 52-Week Change 322.55%
52 Week High 319,870.00
52 Week Low 314,540.00
50-Day Moving Average 316,370.20
200-Day Moving Average 316,542.60

Share Statistics

Avg Vol (3 month) 381.34k
Avg Vol (10 day) 310.77k
Shares Outstanding 514.57M
Implied Shares Outstanding 614.67M
Float 85.42M
% Held by Insiders 162.27%
% Held by Institutions 12.18%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 450
Forward Annual Dividend Yield 40.33%
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 40.23
Payout Ratio 414.58%
Dividend Date 3N/A
Ex-Dividend Date 4Dec 27, 2023
Last Split Factor 21.4:1
Last Split Date 3Apr 11, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin -1.50%
Operating Margin (ttm)-1.28%

Management Effectiveness

Return on Assets (ttm)-1.22%
Return on Equity (ttm)-7.30%

Income Statement

Revenue (ttm)705.76B
Revenue Per Share (ttm)48,430.51
Quarterly Revenue Growth (yoy)-10.80%
Gross Profit (ttm)N/A
EBITDA 629.56M
Net Income Avi to Common (ttm)-10.58B
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)34.7B
Total Cash Per Share (mrq)2,381.19
Total Debt (mrq)70.89B
Total Debt/Equity (mrq)42.32%
Current Ratio (mrq)1.03
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)6.36B
Levered Free Cash Flow (ttm)22.24B